Original article

Construction and direction of a digital diagnosis and treatment system in breast surgery

  • CHEN Xiaosong ,
  • SHEN Kunwei
Expand
  • Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2026-05-25

  Online published: 2026-08-11

Abstract

Breast surgery diagnosis and treatment is gradually transitioning from multi-disciplinary management to digital, intelligent, and precision-based care. Multidimensional data generated during the diagnosis and treatment process—including imaging, pathology, genomics, clinical treatment, follow-up, and rehabilitation provides the foundation for a full-process digital diagnosis and treatment system. Supported by artificial intelligence (AI), cloud platforms, multimodal imaging fusion, and multi-omics integration, this system can cover screening, diagnosis, treatment decision-making, surgical planning, postoperative treatment, and long-term follow-up, thereby paving the way for the digital, intelligent, and precision-based transformation of breast surgery.

Cite this article

CHEN Xiaosong , SHEN Kunwei . Construction and direction of a digital diagnosis and treatment system in breast surgery[J]. Journal of Surgery Concepts & Practice, 2026 , 31(03) : 183 -184 . DOI: 10.16139/j.1007-9610.2026.03.01

References

[1] Eisemann N, Bunk S, Mukama T, et al. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening[J]. Nat Med, 2025, 31(3):917-924.
[2] Elías-Cabot E, Romero-Martín S, Raya-Povedano J L, et al. AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening: a paired, noninferiority trial[J]. Nat Med, 2026, 32(4):1296-1305.
[3] Zheng X, Yao Z, Huang Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer[J]. Nat Commun, 2020, 11(1):1236.
[4] Olawade D B, Oisakede E O, Bello O J, et al. Digital twins in oncology: from predictive modelling to personalised treatment strategies[J]. Crit Rev Oncol Hematol, 2026, 220:105171.
[5] Frenel J S, Heudel P E, Guinaudeau E, et al. Treatment-aware deep learning enables counterfactual prediction of individual benefit from PARP inhibitors in ovarian cancer[J]. NPJ Digit Med, 2026,20.
Outlines

/

〈 〉